{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:38Z","timestamp":1793043098886,"version":"4.5.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR PJT 197879"],"award-info":[{"award-number":["CIHR PJT 197879"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CDF-2014-07-037"],"award-info":[{"award-number":["CDF-2014-07-037"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council Clinician Scientist Fellowship","award":["MR\/Z504026\/1"],"award-info":[{"award-number":["MR\/Z504026\/1"]}]},{"DOI":"10.13039\/501100020261","name":"Eczema Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022722","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022722","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academic Health Sciences Centres of Ontario"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,18]]},"abstract":"<jats:p>Nemolizumab is a new biologic approved to treat atopic dermatitis. In this perspective piece, we use results from our living systematic review and network meta-analysis to provide perspective on the relative efficacy of nemolizumab compared with other approved targeted systemic treatments.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf166","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T15:52:15Z","timestamp":1746633135000},"page":"548-552","source":"Crossref","is-referenced-by-count":18,"title":["Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7388-9475","authenticated-orcid":false,"given":"Aaron M","family":"Drucker","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"Department of Medicine and Women\u2019s College Research Institute, Women\u2019s College Hospital , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantel","family":"Walwyn","sequence":"additional","affiliation":[{"name":"Department of Medicine and Women\u2019s College Research Institute, Women\u2019s College Hospital , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Medicine and Women\u2019s College Research Institute, Women\u2019s College Hospital , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-074X","authenticated-orcid":false,"given":"Zenas Z N","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-8014","authenticated-orcid":false,"given":"Bernd W M","family":"Arents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis I","family":"Spuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prieto-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6286","authenticated-orcid":false,"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"2025081809372828100_ljaf166-B1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"key":"2025081809372828100_ljaf166-B2","doi-asserted-by":"crossref","first-page":"e023061","DOI":"10.1136\/bmjopen-2018-023061","article-title":"Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis","volume":"8","author":"Drucker","year":"2018","journal-title":"BMJ Open"},{"key":"2025081809372828100_ljaf166-B3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamadermatol.2020.0796","article-title":"Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis","volume":"156","author":"Drucker","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2025081809372828100_ljaf166-B4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamadermatol.2022.0455","article-title":"Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis","volume":"158","author":"Drucker","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2025081809372828100_ljaf166-B5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/bjd\/ljad393","article-title":"Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis","volume":"190","author":"Drucker","year":"2024","journal-title":"Br J Dermatol"},{"key":"2025081809372828100_ljaf166-B6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamadermatol.2024.2192","article-title":"Systemic immunomodulatory treatments for atopic dermatitis: living systematic review and network meta-analysis update","volume":"160","author":"Drucker","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025081809372828100_ljaf166-B7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2019.08.013","article-title":"Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic \u00addermatitis and severe pruritus","volume":"145","author":"Silverberg","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2025081809372828100_ljaf166-B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and\u00a0\u00adminimal clinically important difference","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf166\/63104287\/ljaf166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/3\/548\/63104287\/ljaf166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/3\/548\/63104287\/ljaf166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:37:33Z","timestamp":1755524253000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/3\/548\/8126659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5,7]]},"published-print":{"date-parts":[[2025,8,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf166","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,5,7]]}}}